← Dashboard
Aug 26, 2026 05:43 AM ET
Catalyst
FDA/Bio
JAZZ PHARMACEUTICALS PLC (JAZZ) DISCUSSES FDA APPROVAL AND COMMERCIAL LAUNCH OF ZIIHERA FOR FIRST-LINE HER2-POSITIVE GEA - SLIDESHOW - SEEKINGALPHA
FDA approval and commercial launch of Zihera mark key regulatory and revenue catalysts for Jazz.
What changed
Why it matters
FDA approval and commercial launch of Zihera mark key regulatory and revenue catalysts for Jazz.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →